Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planes

被引:44
作者
Kumar, Anita [1 ]
Burger, Irene A. [2 ]
Zhang, Zhigang [3 ]
Drill, Esther N. [3 ]
Migliacci, Jocelyn C. [1 ]
Ng, Andrea [4 ,5 ]
LaCasce, Ann [6 ]
Wall, Darci [7 ]
Witzig, Thomas E. [7 ]
Ristow, Kay [7 ]
Yahalom, Joachim [8 ]
Moskowitz, Craig H. [1 ]
Zelenetz, Andrew D. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA
[2] Univ Zurich Hosp, Dept Med Radiol, Zurich, Switzerland
[3] Mem Sloan Kettering Canc Ctr, Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[4] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[7] Mayo Clin, Dept Hematol, Rochester, MN USA
[8] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
MEDIASTINAL INVOLVEMENT; RADIATION-THERAPY; TRIAL; ABVD; CHEMOTHERAPY; RADIOTHERAPY; ADENOPATHY; MANAGEMENT; RISK;
D O I
10.3324/haematol.2016.141846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Disease bulk is an important prognostic factor in early stage Hodgkin lymphoma, but its definition is unclear in the computed tomography era. This retrospective analysis investigated the prognostic significance of bulky disease measured in transverse and coronal planes on computed tomography imaging. Early stage Hodgkin lymphoma patients (n=185) treated with chemotherapy with or without radiotherapy from 2000-2010 were included. The longest diameter of the largest lymph node mass was measured in transverse and coronal axes on pre-treatment imaging. The optimal cut off for disease bulk was maximal diameter greater than 7 cm measured in either the transverse or coronal plane. Thirty patients with maximal transverse diameter of 7 cm or under were found to have bulk in coronal axis. The 4-year overall survival was 96.5% (CI: 93.3%, 100%) and 4-year relapse-free survival was 86.8% (CI: 81.9%, 92.1%) for all patients. Relapse-free survival at four years for bulky patients was 80.5% (CI: 73%, 88.9%) compared to 94.4% (CI: 89.1%, 100%) for non-bulky; Cox HR 4.21 (CI: 1.43, 12.38) (P=0.004). In bulky patients, relapse-free survival was not impacted in patients treated with chemoradiotherapy; however, it was significantly lower in patients treated with chemotherapy alone. In an independent validation cohort of 38 patients treated with chemotherapy alone, patients with bulky disease had an inferior relapse-free survival [at 4 years, 71.1% (CI: 52.1%, 97%) vs. 94.1% (CI: 83.6%, 100%), Cox HR 5.27 (CI: 0.62, 45.16); P=0.09]. Presence of bulky disease on multidimensional computed tomography imaging is a significant prognostic factor in early stage Hodgkin lymphoma. Coronal reformations may be included for routine Hodgkin lymphoma staging evaluation. In future, our definition of disease bulk may be useful in identifying patients who are most appropriate for chemotherapy alone.
引用
收藏
页码:1237 / 1243
页数:7
相关论文
共 30 条
[1]   HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT - EFFECTIVE MANAGEMENT WITH COMBINED MODALITY THERAPY [J].
BEHAR, RA ;
HORNING, SJ ;
HOPPE, RT .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 25 (05) :771-776
[2]   Assessment and significance of mediastinal bulk in Hodgkin's disease: Comparison between computed tomography and chest radiography [J].
Bradley, AJ ;
Carrington, BM ;
Lawrance, JAL ;
Ryder, WDJ ;
Radford, JA .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2493-2498
[3]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+
[4]   The EORTC strategy in the treatment of Hodgkin's lymphoma [J].
Eghbali, H ;
Raemaekers, J ;
Carde, P .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 :135-140
[5]   Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group [J].
Engert, A ;
Schiller, P ;
Josting, A ;
Herrmann, R ;
Koch, P ;
Sieber, M ;
Boissevain, F ;
de Wit, M ;
Mezger, J ;
Dühmke, E ;
Willich, N ;
Müller, RP ;
Schmidt, BF ;
Renner, H ;
Müller-Hermelink, HK ;
Pfistner, B ;
Wolf, J ;
Hasenclever, D ;
Löffler, M ;
Diehl, V .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) :3601-3608
[6]   Concordance probability and discriminatory power in proportional hazards regression [J].
Gönen, M ;
Heller, G .
BIOMETRIKA, 2005, 92 (04) :965-970
[7]   Hodgkin Lymphoma, Version 2.2012 Featured Updates to the NCCN Guidelines [J].
Hoppe, Richard T. ;
Advani, Ranjana H. ;
Ai, Weiyun Z. ;
Ambinder, Richard F. ;
Aoun, Patricia ;
Bello, Celeste M. ;
Bierman, Philip J. ;
Blum, Kristie A. ;
Chen, Robert ;
Dabaja, Bouthaina ;
Duron, Ysabel ;
Forero, Andres ;
Gordon, Leo I. ;
Hernandez-Ilizaliturri, Francisco J. ;
Hochberg, Ephraim P. ;
Maloney, David G. ;
Mansur, David ;
Mauch, Peter M. ;
Metzger, Monika ;
Moore, Joseph O. ;
Morgan, David ;
Moskowitz, Craig H. ;
Poppe, Matthew ;
Pro, Barbara ;
Winter, Jane N. ;
Yahalom, Joachim ;
Sundar, Hema .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (05) :589-597
[8]   Stage IA-IIB Hodgkin's disease: Management and outcome of extensive thoracic involvement [J].
HughesDavies, L ;
Tarbell, NJ ;
Coleman, CN ;
Silver, B ;
Shulman, LN ;
Linggood, R ;
Canellos, GP ;
Mauch, PM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02) :361-369
[9]   Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions [J].
Klimm, B. ;
Goergen, H. ;
Fuchs, M. ;
von Tresckow, B. ;
Boell, B. ;
Meissner, J. ;
Glunz, A. ;
Diehl, V. ;
Eich, H. T. ;
Engert, A. ;
Borchmann, P. .
ANNALS OF ONCOLOGY, 2013, 24 (12) :3070-3076
[10]   STAGE IA-IIB HODGKINS-DISEASE - STAGING AND TREATMENT OF PATIENTS WITH LARGE MEDIASTINAL ADENOPATHY [J].
LEOPOLD, KA ;
CANELLOS, GP ;
ROSENTHAL, D ;
SHULMAN, LN ;
WEINSTEIN, H ;
MAUCH, P .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (08) :1059-1065